Evidence map›Paper›PMID 38110944›Full record

ArticleBMC public health2023

Cardiovascular health and life expectancy with and without cardiovascular disease in the middle-aged and elderly Chinese population.

Xue Xia, Shuohua Chen, Xue Tian, Qin Xu, Yijun Zhang, Xiaoli Zhang, Penglian Wang, Shouling Wu, Liming Lin, Anxin Wang

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xue Xia *Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Shuohua Chen *Department of Cardiology, Kailuan General Hospital. Tangshan 063000, Hebei, China.
Xue TianDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Qin XuDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Yijun ZhangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Xiaoli ZhangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Penglian WangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Shouling WuDepartment of Cardiology, Kailuan General Hospital. Tangshan 063000, Hebei, China.
Liming LinCardiovascular Laboratory of Kailuan General Hospital. No, 57 Xinhua East Road, Tangshan, 063000, Hebei, China. linliming915@163.com.
Anxin WangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China. wanganxin@bjtth.org.
Beijing Tian Tan Hospital · CNCapital Medical University · CNKailuan General Hospital · CN

Funding

Beijing Natural Science Foundation Haidian original innovation joint fund L222123Fund for Young Talents of Beijing Medical Management Center QML20230505National Key Research and Development Program of China 2022YFC3600600Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University CCMU2022ZKYXZ009
6 · The paper itself

Abstract

backgroundHigh cardiovascular health (CVH) was associated with lower risk of cardiovascular disease (CVD) and longer life expectancy. However, whether life years lived without CVD could increase faster than or at least at the same pace as total lifespan remains unknown. We aimed to explore the associations of CVH status with total life expectancy and life years lived with and without CVD among middle-aged and elderly men and women.

methodsWe included 65,587 participants aged ≥ 45 years from Kailuan study, who were recruited during June 2006 to October 2007. CVH was scored and classified (low [0-49 points], moderate [50-79 points] and high [80-100 points]) with Life's Essential 8, incorporating evaluations of health behaviors and factors. All-cause mortality and incident non-fatal CVD were recorded from baseline to December 31, 2020. The multi-state life table was adopted to explore the associations of CVH status with total life expectancy and life years lived with and without CVD.

resultsSix thousand fifty eight cases of incident non-fatal CVD and 10,580 cases of deaths were identified. Men aged 45 years with low, moderate, and high CVH had a life expectancy of 33.0, 36.5 and 38.5 years, of which 7.8 (23.6%), 6.0 (16.3%) and 3.7 years (9.6%) were spent with CVD. For women, the corresponding life expectancy was 36.6, 43.6 and 48.6 years, and the remaining life years lived with CVD were 7.8 (21.3%), 6.0 (13.7%) and 4.5 years (9.3%), respectively. The benefits of high CVH were persistent across lifespan from age 45 to 85 years and consistent when CVH was evaluated with health behaviors and factors alone.

conclusionsHigh CVH compared with low CVH was associated with longer total life expectancy and fewer years spent with CVD, indicating that promoting CVH is of great importance for CVD prevention and healthy ageing in China.

Indexed as

Cardiovascular DiseasesAgedChinaFemaleHealth BehaviorHealth StatusHumansLife ExpectancyMaleMiddle AgedRisk FactorsCardiovascular DiseaseCardiovascular HealthLife Expectancy

Identifiers

PMID38110944
PMCPMC10726610
OpenAlexW4389895135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.